Image Sourced Mach7 Technologies Limited
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Mach7 Technologies (M7T) signs a contract renewal with Cabell Huntington Hospital in Huntington, West Virginia for a total value of $2.8 million
  • The agreement is for a five-year renewal of Cabell’s Enterprise Imaging Platform along with a five-year renewal on support for the eUnity Diagnostic Enterprise Viewer
  • This renewal converts the existing capital term licence agreement with Cabell to a five-year subscription-based agreement based on image volume
  • According to Mach7, subscription renewals on average have 20 per cent greater overall value than capital licence over the full term
  • Shares in Mach7 are up 3.09 per cent, trading at 50 cents at market close

Mach7 Technologies (M7T) has signed a contract renewal with Cabell Huntington Hospital in Huntington, West Virginia for a total value of $2.8 million.

The agreement is for a five-year renewal of Cabell’s Enterprise Imaging Platform along with a five-year renewal on support for the eUnity Diagnostic Enterprise Viewer.

This renewal converts the existing capital term licence agreement with Cabell to a five-year subscription-based agreement based on image volume.

Mach7 CEO Mike Lampron said the continued support from the company’s existing clients is pleasing.

“This long-term commitment shows the value that Mach7 brings to our clients across the
enterprise,” he said.

“The conversion from a capital model to a subscription model further shows a developing
trend that we are seeing in our business model.

“While this has an impact on the current reporting period, the revenue is contracted and will be recognised annually; overtime, showing greater value and revenue consistency on an annual basis.”

The company said the annual recurring revenue value will begin to recognised on a quarterly basis in the first quarter of the next fiscal year.

According to Mach7, subscription renewals on average have 20 per cent greater overall value than capital licence over the full term.

Shares in Mach7 were up 3.09 per cent, trading at 50 cents at market close.

m7t by the numbers
More From The Market Online

Antipa hits 3.6Moz at Minyari in ‘significant uplift’ for gold-copper-silver project

Antipa Minerals has released a mineral resource estimate (MRE) update for the Minyari gold-copper-silver project in…

Aussie juniors leading the global natural helium hunt as supply crisis threatens

A range of Australian oil and gas juniors are hunting for critical natural helium gas supplies…

PMET hits milestone at Shaakichiuwaanaan CV5 Lithium with ESIA lodging

PMET Resources has lodged key documents for the Shaakichiuwaanaan lithium project in the James Bay region…

Prairie signs ‘monumental’ 10-year offtake deal with Korea’s Hydro for 100% of Phase One production in Saskatchewan

Prairie Lithium (ASX:PL9) has this week signed a binding definitive agreement with South Korean Hydro Lithium for the total